Axa’s Franklin Covey FC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,932
Closed -$478K 425
2025
Q2
$478K Sell
20,932
-1,400
-6% -$31K ﹤0.01% 989
2025
Q1
$617K Hold
22,332
﹤0.01% 903
2024
Q4
$839K Hold
22,332
﹤0.01% 886
2024
Q3
$919K Hold
22,332
﹤0.01% 886
2024
Q2
$849K Hold
22,332
﹤0.01% 898
2024
Q1
$877K Hold
22,332
﹤0.01% 860
2023
Q4
$972K Hold
22,332
﹤0.01% 850
2023
Q3
$958K Buy
+22,332
New +$991K ﹤0.01% 845
2023
Q2
Sell
-17,818
Closed -$685K 1109
2023
Q1
$685K Sell
17,818
-2,500
-12% -$115K ﹤0.01% 924
2022
Q4
$950K Buy
20,318
+13,118
+182% +$640K ﹤0.01% 894
2022
Q3
$327K Hold
7,200
﹤0.01% 1025
2022
Q2
$332K Hold
7,200
﹤0.01% 1027
2022
Q1
$326K Buy
+7,200
New +$334K ﹤0.01% 1097

Other funds holding FC

Axa's FC Position: Q3 2025 in Review

Axa sold out of Franklin Covey (FC) in Q3 2025, closing a stake of 20,932 shares — an estimated $478K sold.

Axa first reported a position in FC in Q1 2022 and held it in 13 quarters. The position peaked at $972K in Q4 2023. 113 funds tracked by Wall St. Rank hold FC as of Q3 2025.

  • Axa reported no remaining Franklin Covey position as of Q3 2025 after selling out during the quarter.
  • Axa sold 20,932 Franklin Covey shares in Q3 2025, an estimated $478K.
  • Axa first reported a position in Franklin Covey in Q1 2022 and held it in 13 quarters.
  • Axa's Franklin Covey position peaked at $972K in Q4 2023.
  • 113 funds tracked by Wall St. Rank held Franklin Covey as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.